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The aim of this study was to assess the number of fever episodes as a risk factor for febrile seizure
recurrence during the first 6 months after the last previous febrile seizure. In a 6-month follow-up
study of 155 children, aged 3 months to 5 y, with a first or a recurrent febrile seizure, the
occurrence of fever episodes and febrile seizure recurrences was prospectively documented. Using
logistic regression analysis the association between the baseline characteristics and the number of
fever episodes and the outcome, a febrile seizure recurrence, was studied. In total, 260 fever
episodes were registered; 29 children experienced 1 or more febrile seizure recurrence during
follow-up. Two factors were associated with febrile seizure recurrence: the number of fever
episodes [odds ratio (OR) = 1.8; 95% confidence interval (CI): 1.4–2.4)] and age at study entry
(OR = 0.6; 95% CI: 0.3–1.1). In a multivariable model, only the number of fever episodes
remained significant. In conclusion, the number of fever episodes increases the risk of a febrile
seizure recurrence with a factor of 1.8 per fever episode in the first 6 months after a febrile
seizure. &Febrile seizure recurrence, logistic regression, number of fever episodes
HA Moll, Sophia Children’s Hospital, Room Sp 1543, Dr Molewaterplein 60, 3015 GJ Rotterdam,
The Netherlands)
Febrile seizures are the most common type of seizures
in children aged 3 months to 5 y, with a cumulative
incidence of 4% (1, 2). The 2-y probability of a febrile
seizure recurrence has been estimated as 30% on
average; 10–20% of the seizures recur within 6 months,
with a decreasing risk after the first 6 months following
the previous seizure (3, 4).
The risk of febrile seizure recurrences has been
studied thoroughly (3–9). The major and most consis-
tent risk factors are: young age at onset, family history
of febrile seizures, previous recurrent febrile seizures, a
low temperature at the initial febrile seizure, a multiple
type initial febrile seizure and short time lapse since the
previous seizure.
In addition, it has been demonstrated that frequent
fever episodes are associated with an increased risk of
recurrence (9, 10). Children have the highest risk of
recurrence in the first 6 months after the last febrile
seizure. This study aimed to assess the incidence of
fever episodes in relation to febrile seizure recurrence
during this high-risk period for febrile seizure recur-
rence.
Patients and methods
Patients
Children aged 3 months to 5 y, who were seen for an
initial or a recurrent febrile seizure at the Sophia
Children’s Hospital in Rotterdam and the Juliana
Children’s Hospital in The Hague between 1 April
1994 and 1 July 1997, were considered for inclusion.
Both outpatients’ clinics include mainly basic specialist
care. Eligible children were enrolled either in a
randomized placebo-controlled trial of ibuprofen syrup
to prevent febrile seizure recurrences (1994–1996), of
which the results will be reported elsewhere, or in a
cohort study, in which the occurrence of fever episodes
and febrile seizure recurrence during 6 months was
registered (1996–1997). The definition of febrile seizure
of the National Institutes of Health Consensus Meeting
(2) was used. The parents of all participating children
gave their written informed consent. The study protocol
was approved by the relevant local ethical review
boards.
Additional inclusion criteria for the children in the
randomized controlled trial were: aged between 1 and 4
y; presence of one or more risk factors for seizure
recurrence, defined as: a positive first-degree family
history of febrile seizures; an initial seizure of the
multiple type; a temperature below 40 ° C at the initial
febrile seizure; and one or more previous febrile seizure
recurrences.
Exclusion criteria for the present study were: more
than 2 months’ time lapse between the last previous
febrile seizure and study entry; current use of anti-
epileptic drugs; no telephone connection; non-Dutch-
and non-English-speaking parents. The randomized
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controlled trial included the children who were allo-
cated to placebo only.
Methods
After the children had visited the emergency room of
the hospital with a febrile seizure, they received an
appointment for special febrile seizure outpatients’
clinic hours, where they were examined and the parents
were given information regarding fever and febrile
seizures. The parents were advised against giving their
child antipyretics during fever.
Baseline characteristics were recorded and checked
at study entry, including age, gender, family history of
febrile seizures and epilepsy, date and characteristics of
the initial febrile seizure, the number of previous
recurrent febrile seizures and the date of the last
previous febrile seizure. The temperature and the
presence of complex characteristics during the initial
febrile seizure were documented. Complex character-
istics were defined as seizure duration of 15 min or
more, recurrence of the seizure within 24 h (multiple
type), and/or a focal onset of the seizure or a postictal
Todd’s paresis of the facial muscles or limbs (focal
characteristics) (11, 12).
If parents consented to participate in the randomized
controlled trial, they were instructed to take the rectal
temperature of the child immediately when the child
seemed ill or feverish and to start promptly to
administer the study medication when the temperature
was 38.5 ° C or higher. They were instructed to record
the precise timing of administering of the study
medication and the height of the temperature on a
standardized patient form and to notify the investigator
of each fever episode and recurrent febrile seizure. If no
fever had been reported after 3 months, the investigator
contacted the parents to ensure participation and to
check the occurrence of fever or febrile seizure
recurrence. When a febrile seizure recurrence occurred,
the follow-up time was considered as terminated for the
randomized trial; however, the parents were asked to
continue to list all subsequent fever episodes and
seizure recurrences until the planned date of study
termination (October 1996).
Parents who consented to participate in the cohort
study were given six diaries. They were instructed to
use subsequently one diary per month of follow-up to
register the occurrence of fever episodes and recurrent
febrile seizures. The parents were instructed to docu-
ment every day whether or not their child was feverish.
When the child seemed ill or feverish, the parents took
the child’s rectal temperature; when it was 38.5 ° C or
more, they were asked to mark that day with ‘yes’ and
when the rectal temperature was lower than 38.5 ° C,
with ‘no’. Accordingly, the occurrence of one or more
febrile seizure recurrences was documented. After
every month of follow-up, the parents sent the diary
to the investigator. If the diary was not received
promptly or if data were not filled in, the parents were
contacted to ensure participation and to check the
occurrence of fever or febrile seizure recurrence.
Statistical analysis
The outcome was defined as the occurrence of a febrile
seizure recurrence within the 6-month follow-up period.
If the follow-up time was terminated before 6 months,
children were excluded from the analysis. Early
termination of follow-up was defined as: development
of afebrile seizures; starting the use of intermittent
prophylactic diazepam; and refusal to participate further
in the study.
Logistic regression analysis was used to assess the
association between baseline characteristics, the num-
ber of fever episodes and the outcome. Baseline
characteristics included the following risk factors for
febrile seizure recurrence: a first-degree family history
of febrile seizures, age at onset <1 y, temperature at the
initial febrile seizure <40 ° C, multiple type initial
febrile seizure and one or more previous recurrent
febrile seizures. All characteristics with p< 0.10 in the
univariable analysis were entered in a multivariable
model, to adjust for their interrelation. Odds ratios (OR)
were used as a measure of association. Associations
were statistically significant (p< 0.05), if the 95%
confidence interval (95% CI) of the OR did not include
the value 1. SPSS for Windows was used for the
analysis.
To assess any difference between the randomized
controlled trial group and the cohort study group,
univariable regression analyses were performed sepa-
rately in each group. If different OR for baseline
characteristics were found, a study-interaction term,
indicating the original study (randomized controlled
trial or cohort study), was introduced into the model and
multiplied by the baseline characteristics involved, to
assess whether differences were likely to be due to
chance.
Results
Study population
The study population consisted of 171 children; 89
(52%) children allocated to the use of placebo in the
randomized controlled trial and 82 (48%) in the cohort
study. Sixteen children of the cohort study were
excluded from the analysis, because of early termina-
tion. Of these, 2 children developed afebrile seizures, 1
child received intermittent prophylactic treatment with
diazepam and 13 parents refused participation after
informed consent had initially been given. Thus, the
data from 155 children were used for the analysis; 89
(57%) children from the randomized controlled trial and
66 (43%) from the cohort study.
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Febrile seizure recurrence during follow-up
Of the 155 children, 29 (19%) children had 1 or more
febrile seizure recurrences and 126 (81%) had no febrile
seizure recurrence during the 6-month follow-up period.
In total, 41 febrile seizures occurred; 20 children
suffered 1 recurrence, 6 children had 2 recurrences
and 3 children had 3 recurrences.
A total of 260 fever episodes was counted in 155
children and the mean number of fever episodes per
child was 1.7. Of all 155 children, 42 (27%) had no
fever episodes and 113 (73%) had 1 or more fever
episodes. Among those 113, 29 children had a febrile
seizure recurrence with 89 fever episodes (mean
number of fever episodes per child 3.1, median 2.0).
The 126 children without a recurrence had 171 fever
episodes (mean 1.4, median 1.0).
As shown in Table 1, in the univariable analysis age
at study entry (OR = 0.6) and number of fever episodes
(OR = 1.8) were associated with febrile seizure recur-
rence (p< 0.10). The other baseline characteristics,
including the risk factors for febrile seizure recurrence,
were not associated with febrile seizure recurrence. In a
multivariable model, the number of febrile episodes was
significantly associated with febrile seizure recurrence.
The risk of a febrile seizure recurrence was increased by
a factor of 1.8 per fever episode in the first 6 months
after the last previous febrile seizure. Age at study entry
had no additional effect on the outcome in the multi-
variable model (OR = 1.0). Children at a young age
experienced more fever episodes than older children
(Fig. 1). From Fig. 1 it can be seen that children with a
recurrence during follow-up experienced more fever
episodes than the other children. For a given number of
fever episodes, the risk of recurrence shows no clear
association with age. Children at a young age had more
recurrences owing to the high number of fever episodes
in young children.
In separate analyses of the randomized controlled
trial and the cohort study, no statistically significant
differences were found in the OR of baseline character-
istics with febrile seizure recurrence. The separate
probabilities of febrile seizure recurrence in the 6-
month follow-up period were 21% in the randomized
controlled trial and 15% in the cohort study (w2,
p = 0.33).
Discussion
This study demonstrates that the number of fever
episodes was a factor independently associated with a
febrile seizure recurrence in the first 6 months after the
last previous febrile seizure. The risk of a febrile seizure
recurrence was increased by a factor of 1.8 per fever
episode; children with febrile seizures who suffer
frequently from feverish illnesses have a high risk of
recurrence. Two follow-up studies of children who had
had an initial febrile seizure found similar results
(9, 10). Rantala and Uhari evaluated retrospectively
the frequency of fever episodes and febrile seizure
recurrences, using a mailed questionnaire. After a mean
follow-up period of 3.8 y, they found that the number of
fever episodes was a significant risk factor for the
recurrence of febrile seizures. Unfortunately, no quan-
tification of the relative risk was reported (9). Knudsen
demonstrated that in the year after an initial febrile
seizure, children who suffer few fever episodes (defined
as fewer than 4 yÿ1) had 0.06 times the risk of febrile
seizure recurrence of children suffering 4 or more fever
episodes per year (OR 1:16) (10). Concordantly, when
the number of fever episodes was categorized in the
Table 1. Baseline characteristics, fever episodes and febrile seizure recurrence.
Recurrence
during follow-up
n = 29
No recurrence
during follow-up
n = 126
Univariable
analysis
Multivariable analysis
(100%) (100%) OR (95% CI) p-value OR (95% CI) p-value
Baseline characteristics
Female gender 13 (45%) 43 (34%) 1.6 (0.7–3.6) 0.28 – –
Age at study entry (in years)a 1.6 (1.3–2.1) 1.8 (1.4–2.6) 0.6 (0.3–1.1) 0.09 1.0 (0.5–1.8) 0.89
Number of febrile episodesa 2.0 (2.0–4.0) 1.0 (0.0–2.0) 1.8 (1.4–2.4) <0.001 1.8 (1.4–2.4) <0.001
aMedian (25–75th percentiles).
Fig. 1. Number of fever episodes in relation to the age at study entry
and febrile seizure recurrence. &: Cases without a febrile seizure
recurrence during follow-up; *: cases with a febrile seizure
recurrence during follow-up.
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present study (fewer than 2 episodes vs 2 or more
episodes per 6 months) a comparable risk reduction of
0.09 was found in the group of children with fewer than
2 fever episodes per 6 months.
In the present study the mean number of fever
episodes per child was 1.7 in 6 months of follow-up.
Children with 1 or more febrile seizure recurrences had
a mean of 3.1, compared with 1.4 in children who
experienced no febrile seizure recurrence, illustrating a
higher frequency of febrile episodes in children with
febrile seizure recurrence. In other febrile seizure
studies, the mean number of fever episodes per child
per year has been reported as 3.0 (10) or was calculated
from the presented data as 1.5–1.9 (9, 13, 14). All of
these studies had a median follow-up time longer than 6
months. The relatively high estimate of 1.7 fever
episodes per 6 months in the present study is probably
due to the fact that the risk over time may not be
constant, since increasing age decreases the incidence
(Fig. 1) (10).
The combination of the data from the randomized
controlled trial and the cohort study is justified, because
both are prospective follow-up studies which were
carried out in the same hospitals, by the same
investigators, within a ongoing study period of 3 y
(1994–1997). All parents had received similar instruc-
tions regarding the use of antipyretics and children had
not received a standardized dose of ibuprofen during
fever. All children had a similar follow-up time at risk
of 6 months. Further separate analysis of the two
original studies showed no difference with respect to the
association of baseline characteristics with febrile
seizure recurrence.
The 6-month probabilities of febrile seizure recur-
rence of both studies were reported separately (21% and
15%, respectively). The fact that the children who had
been participating in the randomized controlled trial had
one or more risk factors at study entry may explain the
slightly higher risk of recurrence. Further, the risk of
recurrence of 15% per 6 months in the cohort study is in
accordance with previously reported average probabil-
ities of 10–20% (3, 4).
The association between the number of fever
episodes and seizure recurrence may suggest that the
factor ‘chance’ plays an important role in the patho-
physiology of febrile seizures. The more fever episodes
a child experiences, the higher the probability of
another recurrent seizure, independent of other risk
factors of febrile seizure recurrence.
The results of this study may have consequences for
the provision of information to parents. If a child
usually suffers from frequent fever episodes, the parents
may be informed of a probable increased risk of seizure
recurrence in the first 6 months after a febrile seizure. If
intermittent preventive treatment (i.e. diazepam during
fever, 1 mg kg body weightÿ1 dÿ1, given in 3 doses) is
considered necessary, because of a very high risk of
recurrence or very frightened parents, the frequency of
fever episodes may play an additional role in this
decision (14). However, parents may also be reassured
because the number of fever episodes will decrease as
the child grows older; thus, the risk of febrile seizure
recurrence will decrease accordingly.
Conclusion
In conclusion, the number of fever episodes is inde-
pendently associated with febrile seizure recurrence.
During the first 6 months after a febrile seizure the risk
of recurrence is increased by a factor of 1.8 per fever
episode.
References
1. Offringa M, Hazebroek-Kampschreur AAJM, Derksen-Lubsen
G. Prevalence of febrile seizures in Dutch schoolchildren.
Paediatr Perinat Epidemiol 1991; 5: 181–8
2. National Institutes of Health Consensus Statement. Febrile
seizures. Pediatrics 1980; 66: 1009–12
3. Offringa M, Bossuyt PMM, Lubsen J, Ellenberg JH, Nelson KB,
Knudsen FU, et al. Risk factors for seizure recurrence in children
with febrile seizures: a pooled analysis of individual patient data
from five studies. J Pediatr 1994; 124: 572–84
4. Offringa M, Derksen-Lubsen G, Bossuyt PMM, Lubsen J.
Seizure recurrence after a first febrile seizure: a multivariate
approach. Dev Med Child Neurol 1992; 34: 15–24
5. El-Radhi AS, Banajeh S. Effect of fever on recurrence rate of
febrile convulsions. Arch Dis Child 1989; 64: 869–70
6. Esch A, van Steyerberg EW, Berger MY, Offringa M, Derksen-
Lubsen G, Habbema JDF. Family history and recurrence of
febrile seizures. Arch Dis Child 1994; 70: 395–9
7. Rantala H, Uhari M, Tuokko H. Viral infections and recurrences
of febrile convulsions. J Pediatr 1990; 116: 195–9
8. Berg AT, Shinnar S, Hauser WA, Alemany M, Shapiro ED,
Salomon ME, Crain EF. A prospective study of recurrent febrile
seizures. N Engl J Med 1992; 327: 1122–7
9. Rantala H, Uhari M. Risk factors for recurrences of febrile
convulsions. Acta Neurol Scand 1994; 90: 207–10
10. Knudsen FU. Frequent febrile episodes and recurrent febrile
convulsions. Acta Neurol Scand 1988; 78: 414–7
11. Berg AT, Steinschneider M, Kang H, Shinnar S. Classification of
complex features of febrile seizures: interrater agreement.
Epilepsia 1992; 33: 661–6
12. , Commission on Epidemiology and Prognosis of the Interna-
tional League against Epilepsy. Guidelines for epidemiologic
studies on epilepsy. Epilepsia 1993; 34: 592–6
13. Uhari M, Rantala H, Vainiopa¨a¨ L, Kurttila R. Effect of
acetaminophen and of low intermittent doses of diazepam on
prevention of recurrences of febrile seizures. J Pediatr 1995; 126:
991–5
14. Rosman PN, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye
EM, et al.. A controlled trial of diazepam administered during
febrile illnesses to prevent recurrence of febrile seizures. N Engl
J Med 1993; 329: 79–84
Received May 11, 1998. Accepted in revised form Aug. 4, 1998
ACTA PÆDIATR 88 (1999) Frequency of fever episodes related to febrile seizure recurrence 55
